Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Post-marketing Real-world Study for Evaluating Effectiveness and Safety of Spartina® (Tirzepatide Manufactured by CinnaGen) in Patients With Obesity and Overweight

NCT07262762 is registered in ClinicalTrials.gov with Cinnagen as lead sponsor.

NCT NCT07262762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07262762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Post-marketing Real-world Study for Evaluating Effectiveness and Safety of Spartina® (Tirzepatide Manufactured by CinnaGen) in Patients With Obesity and Overweight
Lead sponsor
Cinnagen
Phase
Observational
Overall status
Completed
Start date
November 11, 2025
Completion date
July 5, 2026
Enrollment
175 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

obesity & overweight